Celebrating our research achievements
7 April 2017
Researchers and clinicians from Melanoma Institute Australia (MIA) were among the 180 health industry staff, researchers and students whose awards were highlighted at the annual Sydney Medical School’s Celebratory Dinner on 30 March 2017. The evening celebrated the achievements of staff and students from The University of Sydney and its affiliates, like MIA, who have received significant awards during past year.
MIA’s researchers were recognised and celebrated due to their outstanding contributions to health research in Australia.
- Professor John Thompson AO was celebrated for receiving an Honorary Doctorate from Macquarie University and for being named Honorary Fellow of the American College of Surgeons.
- Dr James Wilmott was celebrated for receiving the ‘Wildfire’ Highly Cited Publication Award at the NSW Premier’s Award for Outstanding Cancer Research.
Federal Minister for Health, the Hon. Sussan Ley, announced more than $14 million in funding for a research program to study the molecular determinants of risk, progression and treatment response in melanoma.
If you would like to download a bib for your Melanoma March, we have a selection for you to choose from, print and bring along with you on the day.
Manly Melanoma March has changed to a new location.
We did a short Q&A with two sisters who are raising funds for Melanoma March after sadly losing their mother in 2009. This is their second march and they have shared with us their fundraising tips.
We want to share with you what your valuable Melanoma March donation and fundraising goes towards and our Research Director, Graham Mann explains the national research project the funds will be going towards.
Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.
You are invited to provide comments for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC will consider the registration of the anti-PD1 drug, Keytruda (pembrolizumab) at the next meeting in March.
Melanoma patient Joel Allsop was congratulated today on completing his participation in the international surgical clinical trial, known as MSLT-II. He was the first person in the world to complete the 10 years of follow-up for this trial.
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
Help us march towards a cure for melanoma research. See where your local march is and how you can get involved.
Under the leadership of world-leading melanoma pathologist Prof Richard Scolyer and medical oncologist A/Prof Georgina Long, third year PhD student, Hojabr Kakavand, is at the forefront of melanoma research.
Melanoma Institute Australia has launched a new smartphone app called ClinTrial Refer Melanoma to help busy clinicians find clinical trials for their melanoma patients.
MIA's Associate Professor Georgina Long and stage 4 melanoma patient, Maria, were recently interviewed by ABC Weekend Breakfast about the latest in clincial trials and melanoma treatments.
Sunbed campaigner, Jay Allen, has been acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.
Today we launch the website we’ve dreamed about!
Our new summer campaign has you and your mates' backs covered!
Researcher James Wilmott is working to fill a gap in research for young patients.
Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure!
When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.
Shining new hope for patients with advanced stage melanoma.